National Center for Advancing Translational Sciences in Michigan
National Center for Advancing Translational Sciences (93.350) awarded $75.0 million to recipients in Michigan in 23 grants from fiscal 2021 to 2025, 2.4% of the program's national total. Regents of the University of Michigan received the most, $70.6 million.
- Awarded in Michigan$75.0 million
- Awards23
- Share of the program2.4%
- Rank among states14th of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 9 | $14.9 million |
| FY 2022 | 9 | $10.8 million |
| FY 2023 | 8 | $15.2 million |
| FY 2024 | 9 | $15.6 million |
| FY 2025 | 11 | $18.6 million |
Recipients in Michigan
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Colleges and universities | 17 | $70.6 million |
| Evoq Therapeutics, Inc. | Small businesses | 1 | $2.0 million |
| Innovative Biotherapies, Inc. | Small businesses | 1 | $1.3 million |
| Intero Biosystems Inc. | Small businesses | 1 | $349,952 |
| Grayrain, LLC | Small businesses | 1 | $324,632 |
| Advertent Biotherapeutics, Inc. | Small businesses | 1 | $250,011 |
| Michigan State University Foundation | Colleges and universities | 1 | $148,248 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Michigan?
$75.0 million from fiscal 2021 to 2025, across 23 awards. Michigan ranks 14th of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Michigan?
The largest recipient is Regents of the University of Michigan, with $70.6 million in 17 awards. Next are Evoq Therapeutics, Inc. and Innovative Biotherapies, Inc..
Can organizations in Michigan apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Michigan
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Temporary Assistance for Needy Families
- National School Lunch Program
- Commercial Technologies for Maintenance Activities Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Child Care and Development Block Grant
- Head Start